CVSS2
Attack Vector
NETWORK
Attack Complexity
MEDIUM
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:N/AC:M/Au:N/C:P/I:P/A:P
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
AI Score
Confidence
High
EPSS
Percentile
59.4%
Successful exploitation of this vulnerability could allow an attacker to access privileged accounts.
The following Hillrom cardiology products, when configured to use single sign-on (SSO), are affected:
The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.
CVE-2021-43935 has been assigned to this vulnerability. A CVSS v3 base score of 8.1 has been calculated; the CVSS vector string is (AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H).
Hillrom reported this vulnerability to CISA.
Hillrom plans to release software updates to address this vulnerability in their next software release.
In the interim, Hillrom recommends the following workaround and mitigation to reduce the risk:
Hillrom recommends users upgrade to the latest product versions when updated products are available. Information on how to update these products to their new versions can be found on the Hillrom disclosure page.
Hillrom recommends the following additional workarounds to help reduce risk:
CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov/uscert/ics. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.cisa.gov in the Technical Information Paper, ICS-TIP-12-146-01B–Targeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.
No known public exploits specifically target this vulnerability. This vulnerability has a high attack complexity.
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2021-43935
cisasurvey.gov1.qualtrics.com/jfe/form/SV_9n4TtB8uttUPaM6?product=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-343-01
cwe.mitre.org/data/definitions/288.html
public.govdelivery.com/accounts/USDHSCISA/subscriber/new?topic_id=USDHSCISA_138
twitter.com/CISAgov
twitter.com/intent/tweet?text=Hillrom%20Welch%20Allyn%20Cardio%20Products+https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-343-01
www.cisa.gov/uscert/ics
www.cisa.gov/uscert/ics
www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01
www.cisa.gov/uscert/ics/Recommended-Practices
www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B
www.cisa.gov/uscert/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
www.dhs.gov
www.dhs.gov/foia
www.dhs.gov/performance-financial-reports
www.facebook.com/CISA
www.facebook.com/sharer/sharer.php?u=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-343-01&title=Hillrom%20Welch%20Allyn%20Cardio%20Products
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
www.hillrom.com/en/responsible-disclosures/
www.instagram.com/cisagov
www.linkedin.com/company/cybersecurity-and-infrastructure-security-agency
www.linkedin.com/sharing/share-offsite/?url=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-21-343-01
www.oig.dhs.gov/
www.usa.gov/
www.whitehouse.gov/
www.youtube.com/@cisagov
mailto:?subject=Hillrom%20Welch%20Allyn%20Cardio%20Products&body=www.cisa.gov/news-events/ics-medical-advisories/icsma-21-343-01
CVSS2
Attack Vector
NETWORK
Attack Complexity
MEDIUM
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:N/AC:M/Au:N/C:P/I:P/A:P
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
AI Score
Confidence
High
EPSS
Percentile
59.4%